Amylyx Pharmaceuticals AMLX Earnings Call Transcripts

NASDAQ AMLX
$30.90 +0.69 (+2.28%)
As of: Nov 10, 2026 · 3:59 PM EST
4 earnings calls on file for Amylyx Pharmaceuticals, from Q4 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Amylyx Pharmaceuticals Q3 2026 Earnings Call

Nov 5, 2026 7,413 words · 32 min read
  • Courtney O'LearyDirector of Investor Relations
  • Justin KleeCo-Chief Executive Officer
  • Josh CohenCo-Chief Executive Officer
  • Camille BedrosianChief Medical Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Amylyx Pharmaceuticals Earnings Call Transcripts

Calls4
LatestNov 5, 2026
SinceQ4 2025

Fiscal 2026

Fiscal 2025

All 4 Amylyx Pharmaceuticals transcripts Register to get access to Amylyx Pharmaceuticals’s earnings call transcripts.